MISSION & STRATEGIC OBJECTIVES:
The mission of IASGO is to provide excellence in patient care by administering the highest level of quality in a safe and compassionate environment. We strive to excite, educate, encourage, train and mentor physicians in a spirit of multidisciplinary and interdisciplinary medicine, and help them become excellent caregivers, to develop methods to improve outcomes for patients with a wide variety of malignancies, to use their expertise to benefit their community worldwide, and to become future leaders in academic medicine and/or healthcare delivery. We want to ensure that the revolution of life science discoveries will have global impact in reducing human suffering. IASGO is a professional medical society committed to improving the quality of healthcare worldwide through closer interactions between together surgeons, gastroenterologists and oncologists and dissemination of the best knowledge globally and not in selected centers. To fulfill this mission, IASGO has pursued for almost three decades two strategic objectives: education and clinical translation.
1. Education:
- Disseminate state-of-the-art medical knowledge and expertise through a well-structured and precisely organized system of continued medical education to a global audience, particularly to young specialists from emerging countries.
- Organize courses in close cooperation with national universities or governmental authorities, aiming to update the participants in the newest developments in the field of Surgical, Radiation and Medical Oncology, Endoscopy, and Interventional Radiology.
2. Clinical Translation:
Promote and facilitate at a global scale the interactions (communication and collaborations) between medical professionals specialized in different disciplines to exchange experience and to learn from each other about the indications and limitations of each discipline – in the areas of oncology, gastroenterology and surgery – with the goal of translating new approaches into the clinic through education and conducting clinical trials worldwide.
IASGO Educational Programs are supported through a partnership with Roche